CA Stock MarketDetailed Quotes

COT.H Cotinga Pharmaceuticals Inc

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayMarket Closed Aug 15 09:30 ET
0Market Cap0.00P/E (TTM)

Cotinga Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jan 31, 2020
(Q2)Oct 31, 2019
(Q1)Jul 31, 2019
(FY)Apr 30, 2019
(Q4)Apr 30, 2019
(Q3)Jan 31, 2019
(Q2)Oct 31, 2018
(Q1)Jul 31, 2018
(FY)Apr 30, 2018
(Q4)Apr 30, 2018
Assets
Current assets
Cash, cash equivalents and short term investments
-59.59%46.11K
-65.92%33.57K
-92.96%44.11K
451.45%224.61K
451.45%224.61K
-73.58%114.1K
-92.10%98.51K
-0.12%626.34K
-97.97%40.73K
-97.97%40.73K
-Cash and cash equivalents
-59.59%46.11K
-65.92%33.57K
-92.96%44.11K
451.45%224.61K
451.45%224.61K
-69.67%114.1K
-91.69%98.51K
10.22%626.34K
-94.32%40.73K
-94.32%40.73K
Total current assets
-45.26%229.25K
-46.09%241.63K
-71.86%283.51K
2.65%505.57K
2.65%505.57K
-50.92%418.8K
-75.62%448.21K
-21.26%1.01M
-81.89%492.55K
-81.89%492.55K
Non current assets
-Accumulated depreciation
-1.73%-125.15K
-3.27%-124.99K
-5.81%-124.78K
12.74%-124.2K
12.74%-124.2K
10.87%-123.01K
28.50%-121.04K
30.73%-117.93K
12.87%-142.33K
12.87%-142.33K
-Goodwill
-29.40%680.48K
-29.06%700.81K
-28.15%721.18K
-27.86%741.73K
-27.86%741.73K
-8.74%963.92K
-9.72%987.85K
-20.29%1M
-18.70%1.03M
-18.70%1.03M
-Other intangible assets
-1.34%917.93K
10.94%1.03M
-27.12%1.04M
18.64%951.61K
18.64%951.61K
-38.03%930.41K
-38.10%930.41K
43.61%1.43M
-31.10%802.1K
-31.10%802.1K
Regulatory assets
-83.22%3.19K
-94.43%2.4K
--0
-93.30%4.38K
-93.30%4.38K
-82.36%19.03K
-80.24%43.11K
-76.57%48.8K
-64.81%65.39K
-64.81%65.39K
Total assets
-83.22%3.19K
-94.43%2.4K
--0
-93.30%4.38K
-93.30%4.38K
-82.36%19.03K
-80.24%43.11K
-76.57%48.8K
-64.81%65.39K
-64.81%65.39K
Liabilities
Current liabilities
Current debt and capital lease obligation
--469.68K
--341.89K
--189.3K
--199.97K
--199.97K
----
----
----
----
----
-Current debt
--469.68K
--341.89K
--189.3K
--199.97K
--199.97K
----
----
----
----
----
-Total tax payable
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Current liabilities
69.33%4.81M
63.43%4.31M
37.50%3.84M
17.16%3.65M
17.16%3.65M
30.92%2.84M
31.53%2.64M
51.04%2.79M
-2.90%3.11M
-2.90%3.11M
Non current liabilities
Non current accrued expenses
-97.93%45
-95.23%198
-94.31%413
-91.51%992
-91.51%992
-87.52%2.18K
-84.97%4.15K
-80.62%7.26K
-72.52%11.68K
-72.52%11.68K
Total non current liabilities
69.33%4.81M
63.43%4.31M
37.50%3.84M
17.16%3.65M
17.16%3.65M
30.92%2.84M
26.79%2.64M
39.71%2.79M
-9.26%3.11M
-9.26%3.11M
Shareholders'equity
Share capital
--33.89M
--33.89M
--33.89M
3.05%33.89M
3.05%33.89M
--0
--0
--0
--32.89M
--32.89M
-common stock
--33.89M
--33.89M
--33.89M
3.05%33.89M
3.05%33.89M
--0
--0
--0
--32.89M
--32.89M
Additional paid-in capital
-82.11%7.36M
-82.38%7.25M
-82.16%7.24M
11.16%7.23M
11.16%7.23M
7.00%41.15M
7.39%41.12M
10.44%40.55M
-82.08%6.51M
-82.08%6.51M
Total equity
-34.31%909.78K
-34.55%942.63K
-50.21%1.01M
-18.54%1.25M
-18.54%1.25M
-28.13%1.38M
-51.35%1.44M
-21.65%2.02M
-61.94%1.53M
-61.94%1.53M
(Q3)Jan 31, 2020(Q2)Oct 31, 2019(Q1)Jul 31, 2019(FY)Apr 30, 2019(Q4)Apr 30, 2019(Q3)Jan 31, 2019(Q2)Oct 31, 2018(Q1)Jul 31, 2018(FY)Apr 30, 2018(Q4)Apr 30, 2018
Assets
Current assets
Cash, cash equivalents and short term investments -59.59%46.11K-65.92%33.57K-92.96%44.11K451.45%224.61K451.45%224.61K-73.58%114.1K-92.10%98.51K-0.12%626.34K-97.97%40.73K-97.97%40.73K
-Cash and cash equivalents -59.59%46.11K-65.92%33.57K-92.96%44.11K451.45%224.61K451.45%224.61K-69.67%114.1K-91.69%98.51K10.22%626.34K-94.32%40.73K-94.32%40.73K
Total current assets -45.26%229.25K-46.09%241.63K-71.86%283.51K2.65%505.57K2.65%505.57K-50.92%418.8K-75.62%448.21K-21.26%1.01M-81.89%492.55K-81.89%492.55K
Non current assets
-Accumulated depreciation -1.73%-125.15K-3.27%-124.99K-5.81%-124.78K12.74%-124.2K12.74%-124.2K10.87%-123.01K28.50%-121.04K30.73%-117.93K12.87%-142.33K12.87%-142.33K
-Goodwill -29.40%680.48K-29.06%700.81K-28.15%721.18K-27.86%741.73K-27.86%741.73K-8.74%963.92K-9.72%987.85K-20.29%1M-18.70%1.03M-18.70%1.03M
-Other intangible assets -1.34%917.93K10.94%1.03M-27.12%1.04M18.64%951.61K18.64%951.61K-38.03%930.41K-38.10%930.41K43.61%1.43M-31.10%802.1K-31.10%802.1K
Regulatory assets -83.22%3.19K-94.43%2.4K--0-93.30%4.38K-93.30%4.38K-82.36%19.03K-80.24%43.11K-76.57%48.8K-64.81%65.39K-64.81%65.39K
Total assets -83.22%3.19K-94.43%2.4K--0-93.30%4.38K-93.30%4.38K-82.36%19.03K-80.24%43.11K-76.57%48.8K-64.81%65.39K-64.81%65.39K
Liabilities
Current liabilities
Current debt and capital lease obligation --469.68K--341.89K--189.3K--199.97K--199.97K--------------------
-Current debt --469.68K--341.89K--189.3K--199.97K--199.97K--------------------
-Total tax payable --0--0--0--0--0--0--0--0--0--0
Current liabilities 69.33%4.81M63.43%4.31M37.50%3.84M17.16%3.65M17.16%3.65M30.92%2.84M31.53%2.64M51.04%2.79M-2.90%3.11M-2.90%3.11M
Non current liabilities
Non current accrued expenses -97.93%45-95.23%198-94.31%413-91.51%992-91.51%992-87.52%2.18K-84.97%4.15K-80.62%7.26K-72.52%11.68K-72.52%11.68K
Total non current liabilities 69.33%4.81M63.43%4.31M37.50%3.84M17.16%3.65M17.16%3.65M30.92%2.84M26.79%2.64M39.71%2.79M-9.26%3.11M-9.26%3.11M
Shareholders'equity
Share capital --33.89M--33.89M--33.89M3.05%33.89M3.05%33.89M--0--0--0--32.89M--32.89M
-common stock --33.89M--33.89M--33.89M3.05%33.89M3.05%33.89M--0--0--0--32.89M--32.89M
Additional paid-in capital -82.11%7.36M-82.38%7.25M-82.16%7.24M11.16%7.23M11.16%7.23M7.00%41.15M7.39%41.12M10.44%40.55M-82.08%6.51M-82.08%6.51M
Total equity -34.31%909.78K-34.55%942.63K-50.21%1.01M-18.54%1.25M-18.54%1.25M-28.13%1.38M-51.35%1.44M-21.65%2.02M-61.94%1.53M-61.94%1.53M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg